RICHARD GAYNOR
CIK 1741284 · President of R&D · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.62M
Companies
4
Total Filings
33
Lifetime Open-Market Net
-$189.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALKS | Director | 37,226 | $44.28 | $1.65M | $0 | 16 | 2026-05-22 |
| ZLAB | Director | 56,630 | $17.07 | $966.7K | -$103.7K | 7 | 2026-03-19 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Director | — | $0.04 | — | $0 | 3 | 2022-06-16 |
| Neon Therapeutics, Inc. (NTGN) Delisted | President of R&D | 0 | — | — | -$85.4K | 7 | 2020-05-06 |
Recent Filings · Page 3 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-11 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-21 | ALKS | Mixed | +4,700 | -$30.8K | EDGAR |
| 2020-12-04 | ALKS | Grant (A) | — | $0 | EDGAR |
| 2020-05-22 | ALKS | Grant (A) | — | $0 | EDGAR |
| 2020-05-06 | Neon Therapeutics, Inc. (NTGN) Delisted | Disp (D) | −210,410 | $0 | EDGAR |
| 2020-03-17 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-02 | Neon Therapeutics, Inc. (NTGN) Delisted | Tax (F) | −5,625 | -$8.4K | EDGAR |
| 2020-02-27 | Neon Therapeutics, Inc. (NTGN) Delisted | Tax (F) | −5,465 | -$8.3K | EDGAR |
| 2020-01-13 | Neon Therapeutics, Inc. (NTGN) Delisted | Grant (A) | +65,000 | $0 | EDGAR |
| 2019-12-09 | ALKS | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.